Search

Robert G Tuskan

age ~65

from Keymar, MD

Get Report
Also known as:
  • Rob G Tuskan
  • Bob G Tuskan
Phone and address:
335 Johnsville Rd, Keymar, MD 21757
410 775-2267
Related to:
Connected to:

Robert Tuskan Phones & Addresses

  • 335 Johnsville Rd, Keymar, MD 21757 • 410 775-2267
  • 11715 Clyde Young Rd, Woodsboro, MD 21798 • 301 845-4612
  • 1104 Roland Heights Ave, Baltimore, MD 21211 • 410 366-4370
  • Carroll, MD
  • Laurel, MD
  • Irwin, PA

Work

  • Position:
    Protective Service Occupations

Education

  • Degree:
    High school graduate or higher

Us Patents

  • Virus Coat Protein/Receptor Chimeras And Methods Of Use

    view source
  • US Patent:
    7311920, Dec 25, 2007
  • Filed:
    Oct 6, 2000
  • Appl. No.:
    09/684026
  • Inventors:
    Anthony Louis Devico - Alexandria VA, US
    Timothy R. Fouts - Columbia MD, US
    Robert G. Tuskan - Keymar MD, US
  • Assignee:
    University of Maryland Biotechnology Institute - Baltimore MD
  • International Classification:
    A61K 39/12
  • US Classification:
    4242081, 424 5
  • Abstract:
    The invention relates to chimeric molecules comprising a virus coat sequence and a receptor sequence that can interact with each other to form a complex that is capable of binding a co-receptor. Such chimeric molecules therefore exhibit functional properties characteristic of a receptor-coat protein complex and are useful as agents that inhibit virus infection of cells due to occupancy of co-receptor present on the cell, for example. In particular aspects, the chimeric polypeptide includes an immunodeficiency virus envelope polypeptide, such as that of HIV, SIV, FIV, FeLV, FPV and herpes virus. Receptor sequences suitable for use in a chimeric polypeptide include, for example, CCR5 and CXCR4 sequences.

  • Virus Coat Protein/Receptor Chimeras And Method Of Use

    view source
  • US Patent:
    7399473, Jul 15, 2008
  • Filed:
    May 6, 2005
  • Appl. No.:
    11/124027
  • Inventors:
    Anthony Louis Devico - Alexandria VA, US
    Timothy R. Fouts - Columbia MD, US
    Robert G. Tuskan - Baltimore MD, US
  • Assignee:
    University of Maryland Biotechnology Institute - Baltimore MD
  • International Classification:
    A61K 39/00
  • US Classification:
    4241851, 4241921, 4242041, 4242071, 4242081, 435 71, 435 697, 530350, 536 234
  • Abstract:
    The invention relates to chimeric molecules comprising a virus coat sequence and a receptor sequence that can inter-act with each other to form a complex that is capable of binding a co-receptor. Such chimeric molecules therefore exhibit functional properties characteristic of a receptor-coat protein complex and are useful as agents that inhibit virus infection of cells due to occupancy of a co-receptor present on the cell. In particular aspects, the chimeric polypeptide includes an immunodeficiency virus envelope polypeptide, such as that of HIV, SIV, FIV, FeLV, FPV and herpes virus. Receptor sequences suitable for use in a chimeric polypeptide include, for example, CD4 D1D2 and CD4M9 sequences.

  • Virus Coat Protein/Receptor Chimeras And Methods Of Use

    view source
  • US Patent:
    8183354, May 22, 2012
  • Filed:
    Nov 15, 2007
  • Appl. No.:
    11/940445
  • Inventors:
    Anthony L. DeVico - Alexandria VA, US
    Timothy R. Fouts - Columbia MD, US
    Robert G. Tuskan - Woodsboro MD, US
  • Assignee:
    University of Maryland, Baltimore - Baltimore MD
  • International Classification:
    C07H 23/00
  • US Classification:
    536 231, 4353391, 4352523, 4242081
  • Abstract:
    The invention relates to chimeric molecules comprising a virus coat sequence and a receptor sequence that can inter-act with each other to form a complex that is capable of binding a co-receptor. Such chimeric molecules therefore exhibit functional properties characteristic of a receptor-coat protein complex and are useful as agents that inhibit virus infection of cells due to occn-panty of co-receptor present on the cell, for example. In particular aspects, the chimeric polypeptide includes an immunodeficiency virus envelope polypeptide, such as that of HIV, SIV, FIV, FeLV, FPV and herpes virus. Receptor sequences suitable for use in a chimeric polypeptide include, for example, CCR5 and CXCR4 sequences.

  • Virus Coat Protein/Receptor Chimeras And Methods Of Use

    view source
  • US Patent:
    20020155121, Oct 24, 2002
  • Filed:
    Aug 21, 2001
  • Appl. No.:
    09/934060
  • Inventors:
    Anthony Devico - Alexandria VA, US
    Timothy Fouts - Columbia MD, US
    Robert Tuskan - Baltimore MD, US
  • International Classification:
    A61K039/21
    A61K039/12
    C07K014/155
    C07K014/03
  • US Classification:
    424/186100, 530/350000, 424/188100
  • Abstract:
    The invention relates to chimeric molecules comprising a virus coat sequence and a receptor sequence that can inter-act with each other to form a complex that is capable of binding a co-receptor. Such chimeric molecules therefore exhibit functional properties characteristic of a receptor-coat protein complex and are useful as agents that inhibit virus infection of cells due to occupancy of a co-receptor present on the cell. In particular aspects, the chimeric polypeptide includes an immunodeficiency virus envelope polypeptide, such as that of HIV, SIV, FIV, FeLV, FPV and herpes virus. Receptor sequences suitable for use in a chimeric polypeptide include, for example, CD4 D1D2 and CD4M9 sequences.
Get Report for Robert G Tuskan from Keymar, MD, age ~65
Control profile